Compare Celestica Inc (CLS) vs NetEase Inc (NTES) Price & Performance

Celestica (CLS) trades at $345.18, down 4.08% over 24 hours, with technical indicators showing a bearish trend near key support at $339. The company demonstrates strong fundamentals with Q1 2026 EPS of $2.16 beating estimates, revenue growth accelerating to 55.55% YoY, and a robust ROE of 52.45%. Recent leadership appointments and raised FY2026 revenue guidance to $19 billion reflect operational momentum amid AI and data center demand tailwinds.

Wall Street maintains a bullish outlook with 63% buy ratings and a $440.10 consensus price target, implying 27% upside. Key risks include competitive pressures in the EMS sector and execution challenges in margin expansion. The stock's high P/E of 41.82 warrants monitoring, but earnings beats and institutional confidence support a positive investment case pending Q2 results on July 28, 2026.

NTES trades at $131.43, up 2.66% today, with a bullish technical signal and strong fundamentals. The stock shows robust profitability with a 29.84% net income margin and 22.12% ROE. Recent Q1 2026 earnings beat expectations at $2.53 EPS versus $2.19 forecast. Analyst sentiment is overwhelmingly positive with 82% buy ratings. Cash flow from operations surged to $50.74B in 2025, though net cash flow was negative due to heavy investing activities.

Outlook remains favorable given earnings momentum, international expansion in gaming, and attractive valuation at 16.89 P/E. Risks include reliance on Chinese market and competitive pressures. Wall Street sees 34.7% upside potential based on price targets, supporting a constructive view for long-term investors.